Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × High Grade Serous Carcinoma × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 86 Carcinoma, Non-Small-Cell Lung 77 Prostatic Neoplasms 70 Multiple Myeloma 56 Leukemia, Myeloid, Acute 54 Neoplasms 49 Colorectal Neoplasms 43 Lung Neoplasms 37 Neoplasm Metastasis 35 Ovarian Neoplasms 32 Brain Neoplasms 32 Melanoma 31 Lymphoma 31 Squamous Cell Carcinoma of Head and Neck 29 Pancreatic Neoplasms 29 Triple Negative Breast Neoplasms 27 Recurrence 26 Carcinoma, Renal Cell 26 Urinary Bladder Neoplasms 23 Carcinoma, Hepatocellular 23 Sarcoma 22 Glioblastoma 21 Stomach Neoplasms 20 Lymphoma, Large B-Cell, Diffuse 20 Leukemia, Lymphocytic, Chronic, B-Cell 19 Uterine Cervical Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Follicular 18 Glioma 18 Small Cell Lung Carcinoma 17

Interventions

olaparib 1 ceralasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03462342 2026-03-17

CAPRI

University of Pennsylvania

Phase 2 Completed

High Grade Serous Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡